User menu

Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up.

Bibliographic reference de Ville de Goyet, Maëlle ; Moniotte, Stéphane ; Brichard, Bénédicte. Cardiotoxicity of childhood cancer treatment: update and current knowledge on long-term follow-up.. In: Pediatric hematology and oncology, Vol. 29, no. 5, p. 395-414 (2012)
Permanent URL http://hdl.handle.net/2078/123891
  1. Smith Malcolm A., Seibel Nita L., Altekruse Sean F., Ries Lynn A.G., Melbert Danielle L., O'Leary Maura, Smith Franklin O., Reaman Gregory H., Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century, 10.1200/jco.2009.27.0421
  2. Shankar S. M., Marina N., Hudson M. M., Hodgson D. C., Adams M. J., Landier W., Bhatia S., Meeske K., Chen M. H., Kinahan K. E., Steinberger J., Rosenthal D., Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group, 10.1542/peds.2007-0575
  3. Hudson Melissa M., Survivors of Childhood Cancer: Coming of Age, 10.1016/j.hoc.2008.01.011
  4. Oeffinger Kevin C., Mertens Ann C., Sklar Charles A., Kawashima Toana, Hudson Melissa M., Meadows Anna T., Friedman Debra L., Marina Neyssa, Hobbie Wendy, Kadan-Lottick Nina S., Schwartz Cindy L., Leisenring Wendy, Robison Leslie L., Chronic Health Conditions in Adult Survivors of Childhood Cancer, 10.1056/nejmsa060185
  5. Lipshultz S. E, Alvarez J. A, Scully R. E, Anthracycline associated cardiotoxicity in survivors of childhood cancer, 10.1136/hrt.2007.136093
  6. Kremer L. C. M., Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review, 10.1093/annonc/mdf118
  7. Kremer L. C. M., van der Pal H. J. H., Offringa M., van Dalen E. C., Voute P. A., Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review, 10.1093/annonc/mdf167
  8. van der Pal Helena J.H., van Dalen Elvira C., Kremer Leontien C.M., Bakker Piet J.M., van Leeuwen Flora E., Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review, 10.1016/j.ctrv.2005.03.008
  9. Mulrooney D. A, Yeazel M. W, Kawashima T., Mertens A. C, Mitby P., Stovall M., Donaldson S. S, Green D. M, Sklar C. A, Robison L. L, Leisenring W. M, Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort, 10.1136/bmj.b4606
  10. Tukenova Markhaba, Guibout Catherine, Oberlin Odile, Doyon Françoise, Mousannif Abdeddahir, Haddy Nadia, Guérin Sylvie, Pacquement Hélène, Aouba Albertine, Hawkins Mike, Winter Dave, Bourhis Jean, Lefkopoulos Dimitri, Diallo Ibrahima, de Vathaire Florent, Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer, 10.1200/jco.2008.20.2267
  11. Krischer J P, Epstein S, Cuthbertson D D, Goorin A M, Epstein M L, Lipshultz S E, Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience., 10.1200/jco.1997.15.4.1544
  12. Simbre Valeriano C, Duffy Sarah A, Dadlani Gul H, Miller Tracie L, Lipshultz Steven E, Cardiotoxicity of Cancer Chemotherapy : Implications for Children, 10.2165/00148581-200507030-00005
  13. Lipshultz S E, Sallan S E, Cardiovascular abnormalities in long-term survivors of childhood malignancy., 10.1200/jco.1993.11.7.1199
  14. Temming Petra, Qureshi Amrana, Hardt Juliane, Leiper Alison D., Levitt Gillian, Ancliff Phillip J., Webb David K.H., Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: Retrospective cohort study in a single centre in the United Kingdom, 10.1002/pbc.22908
  15. Sorensen Keld, Levitt Gill A., Bull Catherine, Dorup Inge, Sullivan Ian D., Late anthracycline cardiotoxicity after childhood cancer, 10.1002/cncr.11274
  16. Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A, Villain E, de Vathaire F, Sidi D, Hartmann O, Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy, 10.1038/sj.bjc.6601904
  17. Kremer L. C.M., van Dalen E. C., Offringa M., Ottenkamp J., Voûte P. A., Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study, 10.1200/jco.2001.19.1.191
  18. Güçlü Pınarlı F., Oğuz Aynur, Sedef Tunaoğlu F., Karadeniz Ceyda, Gökçora Nahide, Elbeg Şehri, Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy : Cardiac Status After Anthracyclines, 10.1002/pbc.20281
  19. Poutanen Tuija, Tikanoja Tero, Riikonen Pekka, Silvast Annuli, Perkkiö Mikko, Long-Term Prospective Follow-Up Study of Cardiac Function After Cardiotoxic Therapy for Malignancy in Children, 10.1200/jco.2003.08.050
  20. Lipshultz Steven E., Colan Steven D., Gelber Richard D., Perez-Atayde Antonio R., Sallan Stephen E., Sanders Stephen P., Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood, 10.1056/nejm199103213241205
  21. Hudson Melissa M., Rai Shesh N., Nunez Cesar, Merchant Thomas E., Marina Neyssa M., Zalamea Nia, Cox Cheryl, Phipps Sean, Pompeu Ronald, Rosenthal David, Noninvasive Evaluation of Late Anthracycline Cardiac Toxicity in Childhood Cancer Survivors, 10.1200/jco.2006.09.7451
  22. Rathe Mathias, Carlsen Niels Lauritz Torp, Oxhøj Henrik, Nielsen Gunner, Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2or less for acute lymphoblastic leukemia, 10.1002/pbc.22302
  23. Lipshultz Steven E., Lipsitz Stuart R., Sallan Stephen E., Dalton Virginia M., Mone Suzanne M., Gelber Richard D., Colan Steven D., Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia, 10.1200/jco.2005.12.121
  24. Mavinkurve-Groothuis Annelies M.C., Groot-Loonen Jacqueline, Bellersen Louise, Pourier Milanthy S., Feuth Ton, Bökkerink Jos P.M., Hoogerbrugge Peter M., Kapusta Livia, Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines, 10.1002/pbc.21913
  25. Amigoni Maria, Giannattasio Cristina, Fraschini Donatella, Galbiati Marianna, Capra Anna Clara Maria, Madotto Fabiana, Cesana Francesca, Jankovic Momcilo, Masera Giuseppe, Mancia Giuseppe, Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors, 10.1002/pbc.22637
  26. Möller Torgil R., Garwicz Stanislaw, Barlow Lotti, Winther Jeanette Falck, Glattre Eystein, Olafsdottir Gudridur, Olsen Jörgen H., Perfekt Roland, Ritvanen Annukka, Sankila Risto, Tulinius Hrafn, , Decreasing Late Mortality Among Five-Year Survivors of Cancer in Childhood and Adolescence: A Population-Based Study in the Nordic Countries, 10.1200/jco.2001.19.13.3173
  27. Mertens Ann C., Yasui Yutaka, Neglia Joseph P., Potter John D., Nesbit Mark E., Ruccione Kathy, Smithson W. Anthony, Robison Leslie L., Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor Study, 10.1200/jco.2001.19.13.3163
  28. Adams M. Jacob, Lipshultz Steven E., Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: Implications for screening and prevention, 10.1002/pbc.20352
  29. Lipshultz Steven E., Lipsitz Stuart R., Mone Suzanne M., Goorin Allen M., Sallan Stephen E., Sanders Stephen P., Orav E. John, Gelber Richard D., Colan Steven D., Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer, 10.1056/nejm199506293322602
  30. Silber Jeffrey H., Jakacki Regina I., Larsen Ranae L., Goldwein Joel W., Barber Gerald, Increased risk of cardiac dysfunction after anthracyclines in girls, 10.1002/mpo.2950210704
  31. Adams M. Jacob, Duffy Sarah A., Constine Louis S., Lipshultz Steven E., Cardiovascular Effects of Cancer Therapy, Pediatric Oncology ISBN:3540408401 p.133-159, 10.1007/3-540-26498-1_10
  32. Huang R. S., Duan S., Kistner E. O., Bleibel W. K., Delaney S. M., Fackenthal D. L., Das S., Dolan M. E., Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity, 10.1158/0008-5472.can-07-6381
  33. Blanco Javier G., Leisenring Wendy M., Gonzalez-Covarrubias Vanessa M., Kawashima Toana I., Davies Stella M., Relling Mary V., Robison Leslie L., Sklar Charles A., Stovall Marilyn, Bhatia Smita, Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer, 10.1002/cncr.23534
  34. Van Cutsem Eric, Lambrechts Diether, Prenen Hans, Jain Rakesh K., Carmeliet Peter, Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?, 10.1200/jco.2010.32.2701
  35. Bhatia Smita, Late effects among survivors of leukemia during childhood and adolescence, 10.1016/s1079-9796(03)00072-x
  36. Yeh Edward T.H., Bickford Courtney L., Cardiovascular Complications of Cancer Therapy, 10.1016/j.jacc.2009.02.050
  37. Takemura Genzou, Fujiwara Hisayoshi, Doxorubicin-Induced Cardiomyopathy, 10.1016/j.pcad.2006.10.002
  38. Lyu Y. L., Kerrigan J. E., Lin C.-P., Azarova A. M., Tsai Y.-C., Ban Y., Liu L. F., Topoisomerase II  Mediated DNA Double-Strand Breaks: Implications in Doxorubicin Cardiotoxicity and Prevention by Dexrazoxane, 10.1158/0008-5472.can-07-1649
  39. Billingham M, Cancer Treat Rep., 62, 1607 (1978)
  40. Force T, Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine (2008)
  41. Goldberg MA, Blood., 86, 1114 (1986)
  42. Fulbright JM, Cardiol Res Pract., 2011, 942090 (2011)
  43. Quezado Zenaide M.N., High-Dose Ifosfamide Is Associated with Severe, Reversible Cardiac Dysfunction, 10.7326/0003-4819-118-1-199301010-00006
  44. Yahalom Joachim, Portlock Carol S., Long-Term Cardiac and Pulmonary Complications of Cancer Therapy, 10.1016/j.hoc.2008.01.010
  45. Sengupta Partho P., Northfelt Donald W., Gentile Federico, Zamorano Jose L., Khandheria Bijoy K., Trastuzumab-Induced Cardiotoxicity: Heart Failure at the Crossroads, 10.1016/s0025-6196(11)60840-9
  46. Adams M.Jacob, Hardenbergh Patricia H., Constine Louis S., Lipshultz Steven E., Radiation-associated cardiovascular disease, 10.1016/s1040-8428(01)00227-x
  47. Bölling Tobias, Könemann Stefan, Ernst Iris, Willich Normann, Late Effects of Thoracic Irradiation in Children, 10.1007/s00066-008-1842-2
  48. Cheitlin M. D., ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography), 10.1161/01.cir.0000073597.57414.a9
  49. Kapusta Livia, Thijssen Johan M, Groot-Loonen Jacqueline, Antonius Tim, Mulder Jan, Daniëls Otto, Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines, 10.1016/s0301-5629(00)00252-0
  50. Rathe Mathias, Carlsen Niels L.T., Oxhøj Henrik, Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia, 10.1002/pbc.20313
  51. Xu XY, Zhongguo Dang Dai Er Ke Za Zhi., 13, 490 (2011)
  52. Trachtenberg Barry H., Landy David C., Franco Vivian I., Henkel Jacqueline M., Pearson Elliot J., Miller Tracie L., Lipshultz Steven E., Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer, 10.1007/s00246-010-9878-3
  53. Geyer Holly, Caracciolo Giuseppe, Abe Haruhiko, Wilansky Susan, Carerj Scipione, Gentile Federico, Nesser Hans-Joachim, Khandheria Bijoy, Narula Jagat, Sengupta Partho P., Assessment of Myocardial Mechanics Using Speckle Tracking Echocardiography: Fundamentals and Clinical Applications, 10.1016/j.echo.2010.02.015
  54. Jurcut Ruxandra, Wildiers Hans, Ganame Javier, D’hooge Jan, Paridaens Robert, Voigt Jens-Uwe, Detection and monitoring of cardiotoxicity—what does modern cardiology offer?, 10.1007/s00520-007-0397-6
  55. Çorapçioglu Funda, Sarper Nazan, Berk Fatma, Sahin Tayfun, Zengin Emine, Demir Hakan, EVALUATION OF ANTHRACYCLINE-INDUCED EARLY LEFT VENTRICULAR DYSFUNCTION IN CHILDREN WITH CANCER: A Comparative Study with Echocardiography and Multigated Radionuclide Angiography, 10.1080/08880010500313603
  56. Kremer L.C.M., Tiel-van Buul M.M.C., Ubbink M.C., Offringa M., Ottenkamp J., Olmos R. Valdés, Voûte P.A., Indium-111–Antimyosin Scintigraphy in the Early Detection of Heart Damage After Anthracycline Therapy in Children, 10.1200/jco.1999.17.4.1208
  57. Bryant J., Picot J., Baxter L., Levitt G., Sullivan I., Clegg A., Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: A systematic review, 10.1016/j.ejca.2007.06.012
  58. Dolci Alberto, Dominici Roberto, Cardinale Daniela, Sandri Maria T., Panteghini Mauro, Biochemical Markers for Prediction of Chemotherapy-Induced Cardiotoxicity : Systematic Review of the Literature and Recommendations for Use, 10.1309/ajcpb66lriivmqdr
  59. Cardinale D., Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy, 10.1161/01.cir.0000130926.51766.cc
  60. Oztarhan Kazım, Guler Serhat, Aktas Belgin, Arslan Meliha, Salcioglu Zafer, Aydogan Gonul, The Value of Echocardiography Versus Cardiac Troponin I levels in the Early Detection of Anthracycline Cardiotoxicity in Childhood Acute Leukemia: Prospective Evaluation of a 7-Year-Long Clinical Follow-up, 10.3109/08880018.2011.563772
  61. Lipshultz Steven E., Rifai Nader, Dalton Virginia M., Levy Donna E., Silverman Lewis B., Lipsitz Stuart R., Colan Steven D., Asselin Barbara L., Barr Ronald D., Clavell Luis A., Hurwitz Craig A., Moghrabi Albert, Samson Yvan, Schorin Marshall A., Gelber Richard D., Sallan Stephen E., The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia, 10.1056/nejmoa035153
  62. Lipshultz Steven E, Scully Rebecca E, Lipsitz Stuart R, Sallan Stephen E, Silverman Lewis B, Miller Tracie L, Barry Elly V, Asselin Barbara L, Athale Uma, Clavell Luis A, Larsen Eric, Moghrabi Albert, Samson Yvan, Michon Bruno, Schorin Marshall A, Cohen Harvey J, Neuberg Donna S, Orav E John, Colan Steven D, Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial, 10.1016/s1470-2045(10)70204-7
  63. Lipshultz SE, J Clin Oncol. (2012)
  64. Kremer L.C.M, Bastiaansen B.A.J, Offringa M, Lam J, van Straalen J.P, de Winter R.J, Voûte P.A, Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children, 10.1016/s0959-8049(01)00431-2
  65. Mathew Prasad, Suarez William, Kip Katrinka, Bayar Emel, Jasty Rama, Matloub Yousif, Raisch Dennis, Is There a Potential Role for Serum Cardiac Troponin I as a Marker for Myocardial Dysfunction in Pediatric Patients Receiving Anthracycline-Based Therapy? A Pilot Study, 10.1081/cnv-100103130
  66. Xu XY, Zhongguo Dang Dai Er Ke Za Zhi., 13, 490 (2011)
  67. Bauch Martina, Ester Alice, Kimura Birgitta, Victorica Benjamin E., Kedar Amos, Ian Phillips M., Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects, 10.1002/1097-0142(19920315)69:6<1492::aid-cncr2820690630>3.0.co;2-3
  68. Tikanoja Tero, Riikonen Pekka, Perkkiö Mikko, Helenius Tuula, Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer, 10.1002/(sici)1096-911x(199808)31:2<73::aid-mpo5>3.0.co;2-w
  69. Hayakawa H., Komada Y., Hirayama M., Hori H., Ito M., Sakurai M., Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer, 10.1002/mpo.1155
  70. Snowden J A, Hill G R, Hunt P, Carnoutsos S, Spearing R L, Espiner E, Hart D N J, Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide, 10.1038/sj.bmt.1702507
  71. Soker M, Saudi Med J., 26, 1197 (2005)
  72. Germanakis Ioannis, Kalmanti Maria, Parthenakis Frangiskos, Nikitovic Dragana, Stiakaki Eftichia, Patrianakos Alexander, Vardas Panos E., Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines, 10.1016/j.ijcard.2005.05.006
  73. Ekstein Sivan, Nir Amiram, Rein Azaria JJT, Perles Zeev, Bar-Oz Benjamin, Salpeter Lea, Algur Nurit, Weintraub Michael, N-Terminal-proB-Type Natriuretic Peptide as a Marker for Acute Anthracycline Cardiotoxicity in Children : , 10.1097/mph.0b013e3180640d42
  74. Wassmuth Ralf, Lentzsch Suzanne, Erdbruegger Uta, Schulz-Menger Jeanette, Doerken Bernd, Dietz Rainer, Friedrich Matthias G., Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging—A pilot study, 10.1067/mhj.2001.115436
  75. Oberholzer K, Kunz R P, Dittrich M, Thelen M, Anthrazyklin-induzierte Kardiotoxizität: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen, 10.1055/s-2004-813416
  76. Klika Riggs J., Golik Katharina S., Drum Scott N., Callahan Kathleen E., Thorland William G., Comparison of physiological response to cardiopulmonary exercise testing among cancer survivors and healthy controls, 10.1007/s00421-010-1749-3
  77. De Caro Enrico, Smeraldi Attilio, Trocchio Gianluca, Calevo MariaGrazia, Hanau Guia, Pongiglione Giacomo, Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors, 10.1002/pbc.22606
  78. Children's Oncology Group, Long-Term Follow-Up Guidelines for Survivor of Childhood, Adolescent and Young Adult Cancer (2008)
  79. Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer: a national clinical guideline. January 2004.
  80. Wouters Karlijn A., Kremer Leontien C. M., Miller Tracie L., Herman Eugene H., Lipshultz Steven E., Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies, 10.1111/j.1365-2141.2005.05759.x
  81. van Dalen EC, Cochrane Database Syst Rev., 4, CD005008 (2009)
  82. van Dalen EC, Cochrane Database Syst Rev., 5, CD005006 (2010)
  83. van Dalen EC, Cochrane Database Syst Rev., 2, CD003917 (2008)
  84. Hensley ML, J Clin Oncol., 2008, 127 (27)
  85. Referral procedure on dexrazoxane (Article 31). European Medicines Agency 24/06/2011.
  86. San Juan AF, Recent Results Cancer Res., 186, 319 (2011)
  87. Lipshultz Steven E., Lipsitz Stuart R., Sallan Stephen E., Simbre Valeriano C., Shaikh Seema L., Mone Suzanne M., Gelber Richard D., Colan Steven D., Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood Cancer, 10.1200/jco.2002.12.102
  88. Silber Jeffrey H., Cnaan Avital, Clark Bernard J., Paridon Stephen M., Chin Alvin J., Rychik Jack, Hogarty Alexa N., Cohen Mitchell I., Barber Gerald, Rutkowski Monika, Kimball Thomas R., Delaat Cynthia, Steinherz Laurel J., Zhao Huaqing, Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines, 10.1200/jco.2004.06.022
  89. Cardinale D., Colombo A., Sandri M. T., Lamantia G., Colombo N., Civelli M., Martinelli G., Veglia F., Fiorentini C., Cipolla C. M., Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition, 10.1161/circulationaha.106.635144
  90. Georgakopoulos Peter, Roussou Paraskevi, Matsakas Evangellos, Karavidas Apostolos, Anagnostopoulos Nick, Marinakis Theodoros, Galanopoulos Athanasios, Georgiakodis Fotis, Zimeras Stelios, Kyriakidis Michael, Ahimastos Apostolos, Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up, 10.1002/ajh.21840
  91. Lipshultz S. E., Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines, 10.1542/peds.2004-1004
  92. Levitt Gill, Anazodo Antoinette, Burch Michael, Bunch Kathryn, Cardiac or cardiopulmonary transplantation in childhood cancer survivors: An increasing need?, 10.1016/j.ejca.2009.08.006
  93. Kenney Lisa B, Nancarrow Cheryl Medeiros, Najita Julie, Vrooman Lynda M., Rothwell Monica, Recklitis Christopher, Li Frederick P., Diller Lisa, Health status of the oldest adult survivors of cancer during childhood, 10.1002/cncr.24718
  94. Wasilewski-Masker K, Pediatr Blood Cancer., 54, 976 (2010)
  95. Haddy Theresa B., Mosher Revonda B., Reaman Gregory H., Late Effects in Long-Term Survivors After Treatment for Childhood Acute Leukemia, 10.1177/0009922809332680
  96. Mulrooney Daniel A., Dover Douglas C., Li Suwen, Yasui Yutaka, Ness Kirsten K., Mertens Ann C., Neglia Joseph P., Sklar Charles A., Robison Leslie L., Davies Stella M., , Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia : A report from the Childhood Cancer Survivor Study, 10.1002/cncr.23405
  97. Mody R., Li S., Dover D. C., Sallan S., Leisenring W., Oeffinger K. C., Yasui Y., Robison L. L., Neglia J. P., Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study, 10.1182/blood-2007-10-117150
  98. Aleman B. M. P., van den Belt-Dusebout A. W., De Bruin M. L., van 't Veer M. B., Baaijens M. H. A., Boer J. P. d., Hart A. A. M., Klokman W. J., Kuenen M. A., Ouwens G. M., Bartelink H., van Leeuwen F. E., Late cardiotoxicity after treatment for Hodgkin lymphoma, 10.1182/blood-2006-07-034405
  99. Guldner Laurence, Haddy Nadia, Pein François, Diallo Ibrahima, Shamsaldin Akthar, Dahan Michel, Lebidois Jérome, Merlet Pascal, Villain Elisabeth, Sidi Daniel, Sakiroglu Olivia, Hartmann Olivier, Leftakopoulos Dimitri, de Vathaire Florent, Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer, 10.1016/j.radonc.2006.08.020
  100. Punyko Judith A., Mertens Ann C., Gurney James G., Yasui Yutaka, Donaldson Sarah S., Rodeberg David A., Raney R. Beverly, Stovall Marilyn, Sklar Charles A., Robison Leslie L., Baker K. Scott, Long-term medical effects of childhood and adolescent rhabdomyosarcoma: A report from the childhood cancer survivor study, 10.1002/pbc.20310
  101. Brouwer C., Long-term cardiac follow-up in survivors of a malignant bone tumour, 10.1093/annonc/mdl156
  102. Steinherz Laurel J., Steinherz Peter G., Mangiacasale Deborah, O'Reilly Richard, Allen Jeffrey, Sorell Michael, Miller Denis R., Cardiac changes with cyclophosphamide, 10.1002/mpo.2950090502
  103. Robert Stewart J., Fajardo Luis F., Radiation-induced heart disease: An update, 10.1016/0033-0620(84)90003-3
  104. Mantini G, Rays, 30, 157 (2005)